Skip to main content

Epilepsy

  • Chapter
  • First Online:
Metabolism of Human Diseases
  • 171k Accesses

Abstract

Epilepsy is a complex syndrome comprised of seizures and associated comorbidities affecting approximately 50 million people worldwide. The disease is characterized by excessive electrical discharges in hyperexcitable neuronal clusters that result in spontaneous and recurrent seizures. The seizures may be subclinical and thus only apparent on an electroencephalogram (EEG), but more often they fit into two clinical classifications: partial and generalized. Partial seizures have a focused origin in the brain, and, therefore, seizure symptoms may present in a localized manner. Generalized seizures lack a focal origin and instead involve the entire brain. Epileptic seizures can range from altered states of consciousness to those involving motor function with clonic and/or tonic components.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Steinhauser C, Boison D (2012) Epilepsy: crucial role for astrocytes. Glia 60:1191

    Article  PubMed  Google Scholar 

  2. Boison D (2012) Adenosine dysfunction in epilepsy. Glia 60:1234–1243

    Article  PubMed  Google Scholar 

  3. Newby AC, Worku Y, Holmquist CA (1985) Adenosine formation. Evidence for a direct biochemical link with energy metabolism. Adv Myocardiol 6:273–284

    CAS  PubMed  Google Scholar 

  4. Fredholm BB (2007) Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 14:1315–1323

    Article  CAS  PubMed  Google Scholar 

  5. Boison D (2005) Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 11:25–36

    Article  CAS  PubMed  Google Scholar 

  6. Dragunow M (1991) Adenosine and seizure termination. Ann Neurol 29:575

    Article  CAS  PubMed  Google Scholar 

  7. Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. N Engl J Med 342:314–319

    Article  CAS  PubMed  Google Scholar 

  8. Loscher W, Schmidt D (2011) Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia 52:657–678

    Article  PubMed  Google Scholar 

  9. de Tisi J, Bell GS, Peacock JL, McEvoy AW, Harkness WF, Sander JW, Duncan JS (2011) The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet 378:1388–1395

    Article  PubMed  Google Scholar 

  10. Lutas A, Yellen G (2013) The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci 36:32–40

    Article  CAS  PubMed  Google Scholar 

  11. Masino SA, Li T, Theofilas P, Sandau US, Ruskin DN, Fredholm BB, Geiger JD, Aronica E, Boison D (2011) A ketogenic diet suppresses seizures in mice through adenosine A1 receptors. J Clin Invest 121:2679–2683

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Masino SA, Geiger JD (2008) Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets? Trends Neurosci 31:273–278

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Rothman SM (2009) The therapeutic potential of focal cooling for neocortical epilepsy. Neurotherapeutics 6:251–257

    Article  PubMed  PubMed Central  Google Scholar 

  14. Thompson KW (2005) Genetically engineered cells with regulatable GABA production can affect after discharges and behavioral seizures after transplantation into the dentate gyrus. Neuroscience 133:1029–1037

    Article  CAS  PubMed  Google Scholar 

  15. Boison D (2009) Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies. Epilepsy Res 85:131–141

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Noe F, Nissinen J, Pitkanen A, Gobbi M, Sperk G, During M, Vezzani A (2007) Gene therapy in epilepsy: the focus on NPY. Peptides 28:377–383

    Article  CAS  PubMed  Google Scholar 

  17. McCown TJ (2009) Adeno-associated virus vector-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity. Neurotherapeutics 6:307–311

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Raol YH, Lund IV, Bandyopadhyay S, Zhang G, Roberts DS, Wolfe JH, Russek SJ, Brooks-Kayal AR (2006) Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy. J Neurosci 26:11342–11346

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Detlev Boison .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Wien

About this chapter

Cite this chapter

Plinke, W., Boison, D. (2014). Epilepsy. In: Lammert, E., Zeeb, M. (eds) Metabolism of Human Diseases. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0715-7_5

Download citation

Publish with us

Policies and ethics